Transvalvular Pump Unloading Before Reperfusion to Limit MVO

The patent applies preliminary action by performing mechanical unloading of the left ventricle using an Impella device before reperfusion therapy. This pre-treatment reduces myocardial edema and improves microvascular perfusion pressure prior to reperfusion, thereby mitigating the harmful effects of microvascular obstruction that would otherwise occur during reperfusion. The device is inserted and activated before the reperfusion procedure to prepare the myocardium for successful reperfusion with reduced injury.

The patent applies universality by utilizing the Impella device's multiple functions: it provides mechanical circulatory support to maintain cardiac output, simultaneously unloads the left ventricle to reduce edema, and improves microvascular perfusion. This multi-functional approach allows a single device to address multiple physiological challenges (maintaining output, reducing obstruction, preventing infarction) without requiring separate complex systems for each function.

The patent applies the intermediary principle by using the Impella device as a mediator between the conflicting needs of reducing microvascular obstruction and limiting infarction size. The device mediates this conflict by providing mechanical unloading that reduces edema and improves perfusion pressure, creating conditions that allow safe early reperfusion without the severe microvascular obstruction that would normally occur. This intermediary action enables reperfusion to proceed earlier than would otherwise be safe.